Accurate prediction of dose-dependent CYP3A4 inhibition by itraconazole and its metabolites from in vitro inhibition data. | Clin Pharmacol Ther;88(4): 499-505, 2010 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Accurate prediction of dose-dependent CYP3A4 inhibition by itraconazole and its metabolites from in vitro inhibition data.

Templeton, I; Peng, C-C; Thummel, K E; Davis, C; Kunze, K L; Isoherranen, N.

Affiliation

Templeton I; Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington, USA.

Clin Pharmacol Ther ; 88(4): 499-505, 2010 Oct.

Article in En | MEDLINE | ID: mdl-20739919

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Midazolam / Itraconazole / Enzyme Inhibitors / Cytochrome P-450 CYP3A Inhibitors Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Clin Pharmacol Ther Year: 2010 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Midazolam / Itraconazole / Enzyme Inhibitors / Cytochrome P-450 CYP3A Inhibitors Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Clin Pharmacol Ther Year: 2010 Document type: Article Affiliation country: